Kevin Pollack
Director/Board Member bei PRESSURE BIOSCIENCES, INC.
Vermögen: 6 441 $ am 31.03.2024
Profil
Kevin Andrew Pollack is currently the Chairman of Opiant Pharmaceuticals UK Ltd., an Independent Director of Pressure BioSciences, Inc., and the President of Short Hills Capital LLC.
He previously served as the Managing Director of Paragon Capital Advisors LLC (New York) and Paragon Capital LP, CFO, Secretary, Treasurer & Director of Opiant Pharmaceuticals, Inc., and an Independent Director of BBHC, Inc. and Taronis Fuels, Inc. He also served as an Independent Non-Executive Director of BlueNRGY Group Ltd.
In terms of education, he holds a graduate degree and an MBA from Vanderbilt University and an undergraduate degree from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.03.2024 | 36 787 ( 0,14% ) | 6 438 $ | 31.03.2024 | |
| 21.02.2024 | 21 ( 0,28% ) | 4 $ | 31.03.2024 |
Aktive Positionen von Kevin Pollack
| Unternehmen | Position | Beginn |
|---|---|---|
| PRESSURE BIOSCIENCES, INC. | Director/Board Member | 03.07.2012 |
Short Hills Capital LLC
 Short Hills Capital LLC Investment Banks/BrokersFinance Short Hills Capital LLC is a private company based in Short Hills, NJ. | President | 01.01.2003 |
Opiant Pharmaceuticals UK Ltd.
 Opiant Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Indivior PLC, Opiant Pharmaceuticals UK Ltd. is a private company that manufactures pharmaceutical preparations. The company is based in Manchester, UK. | Chairman | 01.01.2016 |
Ehemalige bekannte Positionen von Kevin Pollack
| Unternehmen | Position | Ende |
|---|---|---|
| TARONIS FUELS, INC. | Director/Board Member | 08.04.2021 |
| BBHC INC. | Director/Board Member | 30.09.2020 |
| OPIANT PHARMACEUTICALS, INC. | Director of Finance/CFO | 01.01.2017 |
Paragon Capital Advisors LLC (New York)
 Paragon Capital Advisors LLC (New York) Investment ManagersFinance Paragon Capital Advisors LLC is an independent hedge fund manager headquartered in New York City. The firm was founded in 2005 and manages assets on behalf of institutional clients and private investors. | Portfolio Manager-Equities | 01.01.2013 |
| Paragon Capital LP | Chief Executive Officer | 01.01.2013 |
Ausbildung von Kevin Pollack
| Vanderbilt University | Graduate Degree |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PRESSURE BIOSCIENCES, INC. | Health Technology |
| TARONIS FUELS, INC. | Process Industries |
| Private Unternehmen | 8 |
|---|---|
Short Hills Capital LLC
Short Hills Capital LLC Investment Banks/BrokersFinance Short Hills Capital LLC is a private company based in Short Hills, NJ. | Finance |
Paragon Capital Advisors LLC (New York)
Paragon Capital Advisors LLC (New York) Investment ManagersFinance Paragon Capital Advisors LLC is an independent hedge fund manager headquartered in New York City. The firm was founded in 2005 and manages assets on behalf of institutional clients and private investors. | Finance |
BBHC, Inc.
 BBHC, Inc. Electric UtilitiesUtilities BBHC, Inc. is a technology company, which engages in the production of a plasma based system for the gasification and sterilization of liquid waste. Its products include magnesGas2, magneTote, and co-combustion. The company was founded by Ruggero Maria Santilli on December 9, 2005 and is headquartered in Peoria, AZ. | Utilities |
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
BlueNRGY Group Ltd.
 BlueNRGY Group Ltd. Engineering & ConstructionIndustrial Services BlueNRGY Group Ltd. engages in designing and installing systems for generating electricity from solar and other renewable sources. It also offers engineered solutions for the management of distributed power generation and climate control/energy efficiency systems. The company founded on August 18, 1989 and is headquartered in Sydney, Australia. | Industrial Services |
| Paragon Capital LP | Miscellaneous |
Opiant Pharmaceuticals UK Ltd.
Opiant Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Indivior PLC, Opiant Pharmaceuticals UK Ltd. is a private company that manufactures pharmaceutical preparations. The company is based in Manchester, UK. | Health Technology |
Sidley Austin LLP
 Sidley Austin LLP Miscellaneous Commercial ServicesCommercial Services Sidley Austin LLP is a premier legal adviser with over 2000 lawyers in 20 offices worldwide. Sidley Austin is based in Chicago, IL and has subsidiaries in Germany, Hong Kong, United States, United Kingdom, and Japan. The firm has been providing superior client service for over 150 years and has a diverse group of legal professionals from many cultures who are dedicated to teamwork and collaboration. Sidley Austin has forged enduring relationships with the business community and serves a varied and high-caliber group of market leaders, many of whom are pioneers in their respective industries and professions. The firm is committed to pro bono service and its lawyers and staff devote more than 100,000 hours annually to serving those most in need. | Commercial Services |
